🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of SR...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05
Trial ID
NCT00933530
The primary objective of this study is to assess the pharmacokinetic profil...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-20
Trial ID
NCT00938275
Treatments Being Tested
Randomized, placebo-controlled, parallel-group, double-blind, multiple-dose...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-03-03
Trial ID
NCT01018017
The main purpose of this study is to investigate the effect of SRT2104 upon...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01039909
The purpose of this study is to assess the pharmacokinetic profile, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-23
Trial ID
NCT00933062
This is an open-label, randomized, controlled, single center study to asses...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-30
Trial ID
NCT01702493
The primary purpose of this study is to determine the safety and tolerabili...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-19
Trial ID
NCT00937326
The primary objective is to determine the pharmacokinetics, safety and tole...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-01
Trial ID
NCT00964340
The purpose of this research study is to: * 1\) Test the safety and tolera...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-13
Trial ID
NCT01453491
Treatments Being Tested